MapLight Therapeutics, Inc.
MPLT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $27 | $27 | $20 | $21 |
| G&A Expenses | $4 | $0 | $0 | $2 |
| SG&A Expenses | $4 | $4 | $4 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $31 | $31 | $23 | $23 |
| Operating Income | -$31 | -$31 | -$24 | -$23 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $2 | $1 | $1 | $2 |
| Pre-Tax Income | -$29 | -$30 | -$22 | -$21 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$29 | -$30 | -$22 | -$21 |
| % Margin | – | – | – | – |
| EPS | -0.71 | -0.72 | -0.54 | -0.51 |
| % Growth | 1.4% | -33.3% | -5.9% | – |
| EPS Diluted | -0.71 | -0.72 | -0.54 | -0.51 |
| Weighted Avg Shares Out | 41 | 41 | 41 | 41 |
| Weighted Avg Shares Out Dil | 41 | 41 | 41 | 41 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $1 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$31 | -$30 | -$22 | -$23 |
| % Margin | – | – | – | – |